Alternative medicine use and breast cancer (2012 update)
[Editor’s note: It’s a holiday here in the U.S.; consequently, here is a “rerun” from my other super not-so-secret other blog. It’s not a complete rerun. I’ve tweaked it a bit. If you don’t read my other blog, it’s new to you. If you do, it’s partially new to you. See you all next week with brand spankin’ new material. It also...
The “central dogma” of alternative/complementary/integrative medicine
There is something in molecular biology and genetics known as the “central dogma.” I must admit, I’ve always hated the use of the word “dogma” associated with science, but no less a luminary than Francis Crick first stated it in 1958, and it has been restated over the years in various ways. Perhaps my favorite version of the central dogma was succinctly...
Related by coincidence only? University and medical journal press releases versus journal articles
There are certain topics in Science-Based Medicine (or, in this case, considering the difference between SBM and quackery) that keep recurring over and over. One of these, which is of particular interest to me because I am a cancer surgeon specializing in breast cancer, is the issue of alternative medicine use for cancer therapy. Yesterday, I posted a link to an interview...
Dr. Gorski pontificates about the Gerson Therapy on Uprising Radio
Every so often I get requests to be interviewed on the radio about skeptical topics. Now, why anyone would ever want to interview me, who knows? But they do, and when I can manage to accommodate reporters or interviewers, I do. Last week, I was interviewed on Uprising Radio, in which I discussed alternative medicine (particularly the Gerson therapy for cancer). My...
The mammography wars heat up again (2012 edition)
One issue that keeps coming up time and time again for me is the issue of screening for cancer. Because I’m primarily a breast cancer surgeon in my clinical life, that means mammography, although many of the same issues come up time and time again in discussions of using prostate-specific antigen (PSA) screening for prostate cancer. Over time, my position regarding how...
The perils and pitfalls of “patient-driven” clinical research
Dying of cancer can be a horrible way to go, but as a cancer specialist I sometimes forget that there are diseases that are equally, if not more, horrible. One that always comes to mind is amyotropic lateral sclerosis (ALS), more commonly known as Lou Gehrig’s disease. It is a motor neuron disease whose clinical course is characterized by progressive weakness, muscle...
Meet the new drugs, same as the old drugs?
“Targeted therapy.” It’s the holy grail of cancer research these days. If you listen to its most vocal proponents, it’s the path towards “personalized medicine” that improves survival with much lower toxicity. With the advent of the revolution in genomics that has transformed cancer research over the last decade, including the petabytes of sequence and gene expression data that pour out of...
Caption this: Dr. Gorski meets Dr. Whitaker
Earlier today, I gave you the blow-by-blow description of a debate that occurred on Thursday between Dr. Steve Novella and Dr. Julian Whitaker. After that debate, I got an opportunity to “discuss” one of Dr. Whitaker’s points, specifically a scientifically illiterate graph that he had constructed. Because Dave Patton was there doing photography of the event for Michael Shermer, I suggested that...
Steve Novella vs. Julian Whitaker on vaccines at FreedomFest
While I and some of the others in the SBM crew were at The Amazing Meeting (TAM) in Las Vegas, our fearless leader Steve Novella got an interesting challenge: To debate Dr. Julian Whitaker about vaccines at a libertarian confab known as FreedomFest, which just so happened to be going on up the strip a piece at the same time TAM was....
The future of cancer therapy?
I was contemplating writing a post along the same lines as Harriet’s post about evolutionary medicine last week, but then on Sunday morning I saw an article that piqued my interest. Sorry, Harriet, my response, if I get to it, might have to wait until next week, although we could always discuss the usefulness (versus the lack thereof) of evolutionary medicine over...